Does NILOTINIB Cause Type v hyperlipidaemia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Type v hyperlipidaemia have been filed in association with NILOTINIB (nilotinib). This represents 0.0% of all adverse event reports for NILOTINIB.
5
Reports of Type v hyperlipidaemia with NILOTINIB
0.0%
of all NILOTINIB reports
2
Deaths
0
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From NILOTINIB?
Of the 5 reports, 2 (40.0%) resulted in death.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which NILOTINIB Alternatives Have Lower Type v hyperlipidaemia Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB